Literature DB >> 10607806

The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction?

P Calverley1, D Bellamy.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10607806      PMCID： PMC1745601          DOI： 10.1136/thorax.55.1.78

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  17 in total

1.  FEV1 and PEF in COPD management.

Authors:  D Nolan; P White
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

2.  EUROSCOP, ISOLDE and the Copenhagen city lung study.

Authors:  P S Burge
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

3.  Muscle weakness is related to utilization of health care resources in COPD patients.

Authors:  M Decramer; R Gosselink; T Troosters; M Verschueren; G Evers
Journal:  Eur Respir J       Date:  1997-02       Impact factor: 16.671

4.  Acute bronchitis and clinical outcome three years later: prospective cohort study.

Authors:  J S Jónsson; T Gíslason; D Gíslason; J A Sigurdsson
Journal:  BMJ       Date:  1998-11-21

5.  Quality of life changes in COPD patients treated with salmeterol.

Authors:  P W Jones; T K Bosh
Journal:  Am J Respir Crit Care Med       Date:  1997-04       Impact factor: 21.405

6.  Evaluation of a self-management plan for chronic obstructive pulmonary disease.

Authors:  P B Watson; G I Town; N Holbrook; C Dwan; L J Toop; C J Drennan
Journal:  Eur Respir J       Date:  1997-06       Impact factor: 16.671

7.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease.

Authors:  Y Lacasse; E Wong; G H Guyatt; D King; D J Cook; R S Goldstein
Journal:  Lancet       Date:  1996-10-26       Impact factor: 79.321

8.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

9.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study.

Authors:  E Prescott; A M Bjerg; P K Andersen; P Lange; J Vestbo
Journal:  Eur Respir J       Date:  1997-04       Impact factor: 16.671

10.  Treatment of adult asthma: is the diagnosis relevant?

Authors:  P Littlejohns; S Ebrahim; R Anderson
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139
View more
  12 in total

Review 1.  Animal models of chronic obstructive pulmonary disease.

Authors:  P A Dawkins; R A Stockley
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Inhaled steroids for COPD?

Authors:  A E Tattersfield; T W Harrison
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

Review 3.  Pulmonary rehabilitation.

Authors: 
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

Review 4.  Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.

Authors:  R Mahadeva; S D Shapiro
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

5.  Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample.

Authors:  L Shahab; M J Jarvis; J Britton; R West
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

Review 6.  Chronic obstructive pulmonary disease 8: non-pharmacological management of COPD.

Authors:  M D L Morgan; J R Britton
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 7.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409

8.  Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol.

Authors:  Dave Singh; Anthony D D'Urzo; Ferran Chuecos; Anna Muñoz; Esther Garcia Gil
Journal:  Respir Res       Date:  2017-05-30

Review 9.  The Clinical Use of Stem Cell Research in Chronic Obstructive Pulmonary Disease: A Critical Analysis of Current Policies.

Authors:  Domenico Maurizio Toraldo; Sara Toraldo; Luana Conte
Journal:  J Clin Med Res       Date:  2018-07-31

Review 10.  Pharmacoeconomics in COPD: lessons for the future.

Authors:  Helen J Starkie; Andrew H Briggs; Mike G Chambers
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.